Divided U.S. Supreme Court turns to less sensitive IP cases
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
The U.S. Supreme Court building is seen in Washington, March 16, 2016. President Barack Obama on Wednesday nominated Appeals Court Judge Merrick Garland to the U.S. Supreme Court. REUTERS/Jim Bourg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
By Lawrence Hurley
WASHINGTON (Reuters) - Shorthanded and ideologically divided, the U.S. Supreme Court has yet to take up any cases on politically sensitive social issues in its new term starting in October, instead showing a keen interest in more technical cases of importance to business such as disputes over intellectual property.
In addition to four intellectual property cases it has already agreed to hear, the court could as soon as next week take up a trademark battle that pits an Asian-American rock band and the Washington Redskins football team against the U.S. Patent and Trademark Office.
Later in the year, the court could take up a quirky copyright fight between a woman and a record company over a video she posted online of her toddler son dancing to a Prince song.
The lineup so far is in contrast to the court's last term, in which it heard major cases on abortion, racial preferences and immigration in which it was closely divided. Those cases were taken up before the death of conservative Antonin Scalia in February, which left what is usually a nine-member court with a vacancy that shows no sign of being filled until next year due to the Republican-controlled Senate's refusal to consider President Barack Obama's nominee.
Although the court has not taken up any cases of such social or political magnitude for the coming term, it's possible it could do so before it ends in June. The battle over whether transgender students can use bathrooms that match their gender identity is one candidate.
It is not unusual for the court to take up a handful of intellectual property (IP) cases among the 70 or so it selects for oral argument but this year there is a greater incentive than ever because they are often decided by unanimous or lopsided votes.
(Graphic on the Supreme Court's handling of intellectual property cases: http://tmsnrt.rs/2cZmi4S)
Legal experts say the justices might seek to avoid cases on which they could split 4-4. Such splits occurred four times after Scalia’s death, and provide little legal clarity, as there’s no written decision and no national precedent set.
“I do think the court will be looking for cases that don't break along traditional partisan lines. IP cases fit that bill,” said Mark Lemley, a law professor at Stanford Law School.
Such cases, on patent law, copyright and trademarks, can have high financial stakes, especially when companies fight over lucrative patent protections. One of the four IP cases already taken up include a $400 million patent dispute between Samsung Electronics Co Ltd and Apple Inc over the design of the iPhone, which will be heard on Oct. 11.
"DANCING BABY" CASE
In the court’s last term, it heard three intellectual property cases, with two decided 8-0 and one 7-1, in line with the vote counts in similar cases in recent years.
The trend in recent years, at least in patent cases, is for the court to frequently reverse appeals court rulings that are overly protective of patent rights. There is less of a pattern in trademark and copyright cases.
Some lawyers think the court may have lowered its standards for the coming term, accepting cases that it can dispose of without 4-4 votes. The court can take cases for various reasons, such as to resolve splits between lower courts or to decide a question of pressing national importance.
IP law experts cited one of the patent cases, a dispute over whether genetic-testing kits made by biotechnology company Life Technologies Corp, now part of Thermo Fisher Scientific Inc infringed upon patents held by Promega Corp as an example in part because the issue is narrow and it has little chance of affecting other cases.
Charles Duan, a lawyer with digital advocacy group Public Knowledge, was among those who questioned why the court took the Promega case, saying it "doesn't have much of a direct impact on the public."
IP cases the court could still decide to hear this term include the two disputes over whether offensive trademarks can be canceled.
The Slants rock band, whose members are Asian-American, chose the name specifically to reclaim a term used to disparage Asians. But its application for a trademark was rejected by the federal trademark office.
In the other case, the Washington Redskins organization has long trademarked its name and objected when the trademark office sought to cancel it because it was deemed to disparage Native Americans.
The court will also decide whether to hear the copyright dispute dubbed the “dancing baby” case over a video posted online that showed a toddler dancing to Prince song “Let’s Go Crazy”.. The legal question is whether copyright holders can face damages if they incorrectly tell someone to take down content posted online that is protected by the so-called “fair use” doctrine, which allows unauthorized use of copyrighted material in some circumstances.
The court has also showed provisional interest in three other intellectual property-related cases by asking the Obama administration to file briefs offering its opinion on whether they should be taken up.
One closely-watched case on that list concerns Novartis AG's bid to launch a copycat version of Amgen Inc's cancer drug Neupogen, which IP law experts say the court could take up because it is the first to reach the high court on a new law addressing so-called biosimilar drugs.
(Reporting by Lawrence Hurley; editing by Stuart Grudgings.)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Turkish jets hit 39 Islamic State targets, kill four militants - army
- CIA says Russia intervened to help Trump win White House
- Trump names Dow Chemical CEO Liveris to head Manufacturing Council
Create E-mail Alert Related CategoriesReuters
Related EntitiesBarack Obama
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!